Data from the 2013 EU Safety and Effectiveness Clinical Trial: Venous Leg Ulcer (VLU) Study is available at slide 10 of the FTT announcement issued 3 Mar 2014. The results have no doubt also been presented in subsequent FTT presentations.
Find it by searching ASX 2014 FTT announcements
https://www.asx.com.au/asx/statistics/announcements.do
There was no placebo, 36% of 45 patients healed 100%, 67% had greater than 50% wound reduction.
- Forums
- ASX - By Stock
- DLM
- Ann: Investor Presentation
Ann: Investor Presentation, page-20
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DLM (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.227M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
DLM (ASX) Chart |
Day chart unavailable